Phreesia, Inc.

LSE:0A23.LHealthcare

——At close · Market cap —

0A23.L · Income statement · TradingHolo

USD millions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Revenue	148.7	213.2	280.9	356.3	419.8	480.6	+14.5%
Cost of revenue	70.3	105.9	138.0	124.0	164.6	186.1	+13.1%
Gross profit	78.4	107.3	142.9	232.3	255.2	294.4	+15.4%
Research & development	22.6	52.3	91.2	121.9	117.4	121.5	+3.5%
Selling, general & administrative	83.2	174.4	231.6	222.2	192.8	170.4	−11.6%
Selling & marketing	43.0	106.4	151.3	147.0	121.1	0.0	−100.0%
Operating expenses	103.7	223.2	319.4	368.8	310.2	291.8	−5.9%
Operating income	(25.3)	(115.8)	(176.6)	(136.5)	(55.0)	2.6	+104.7%
Interest expense	1.7	1.2	1.4	1.9	2.3	7.0	+196.3%
Interest income	0.1	0.1	2.5	4.1	2.7	2.2	−18.8%
Other income / expense	(1.9)	(2.1)	0.9	1.1	(0.8)	(11.6)	−1308.7%
Pre-tax income	(27.2)	(118.0)	(175.7)	(135.3)	(55.8)	(8.9)	+84.0%
Income tax	0.0	0.2	0.5	1.5	2.7	(11.2)	−514.1%
Net income	(27.3)	(118.2)	(176.1)	(136.9)	(58.5)	2.3	+103.9%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—
EPS, basic (per share)	(0.69)	(2.37)	(3.36)	(2.51)	(1.02)	0.04	+103.8%
EPS, diluted (per share)	(0.69)	(2.37)	(3.36)	(2.51)	(1.02)	0.04	+103.7%
EBITDA	(7.6)	(92.3)	(145.5)	(102.9)	(23.8)	34.6	+245.7%
Depreciation & amortization	17.9	24.5	28.8	30.5	29.7	32.0	+7.8%
Weighted average shares (shares)	39,519,640	49,888,436	52,440,067	54,561,449	57,589,687	59,737,915	+3.7%
Weighted average diluted shares (shares)	39,519,640	49,888,436	52,440,067	54,561,449	57,589,687	61,494,878	+6.8%
Gross margin	52.7%	50.3%	50.9%	65.2%	60.8%	61.3%	+0.5 pts
Operating margin	−17.0%	−54.3%	−62.9%	−38.3%	−13.1%	0.5%	+13.6 pts
Net margin	−18.4%	−55.4%	−62.7%	−38.4%	−13.9%	0.5%	+14.4 pts

USD millionsUpdated Sat 31 Jan ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.